Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825

  • Joshua D. Strauss
  • , Mark R. Gilbert
  • , Minesh Mehta
  • , Ang Li
  • , Renke Zhou
  • , Melissa L. Bondy
  • , Erik P. Sulman
  • , Ying Yuan
  • , Yanhong Liu
  • , Elizabeth Vera
  • , Merideth M. Wendland
  • , Volker W. Stieber
  • , Vinay K. Puduvalli
  • , Serah Choi
  • , Nina L. Martinez
  • , H. Ian Robins
  • , Grant K. Hunter
  • , Chi Fan Lin
  • , Vivian A. Guedes
  • , Melissa A. Richard
  • Stephanie L. Pugh, Terri S. Armstrong, Michael E. Scheurer

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)767-778
Number of pages12
JournalNeuro-Oncology
Volume27
Issue number3
DOIs
StatePublished - Mar 1 2025

ASJC Scopus Subject Areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Keywords

  • bevacizumab
  • genome-wide association study
  • glioblastoma
  • hypertension
  • thrombosis

Cite this